Cannabis Law Report
SEPTEMBER 11, 2021
The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.
Cannabis Law Report
JUNE 15, 2021
The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
SEPTEMBER 18, 2021
The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.
Cannabis Law Report
JUNE 9, 2021
The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.
The Blunt Truth
AUGUST 13, 2019
Current federal law expressly allows for the distribution of hemp-derived CBD products that contain 0.3% The FDA has provided clarity that hulled hemp seed, hemp protein powder, and hemp seed oil can be legally used in foods. Other CBD products, however, are still subject to various state law regulations as well as the U.S.
Cannabis Law Report
MARCH 19, 2020
FDA’s announcement comes on the heels of an active 2019, during which both FDA and the FTC issued warning letters to marketers of CBD products 1 and the plaintiffs’ bar began to actively file class-action lawsuits against marketers of CBD products under state law. Godfrey , Evelina J. Arnold & Porter.
Cannabis Law Report
SEPTEMBER 12, 2022
A declarations page summarizes the coverage, defines who the insured is (also an issue in coverage cases), and states the various monetary limits to various types of coverage. When an insured sues an insurer for refusing to pay a claim, it is referred to as a “first party” or in some states, a “bad faith” lawsuit.
Expert insights. Personalized for you.
105 
Let's personalize your content